Sequence and Functional Analysis of PPE Proteins from Mycobacterium Leprae

Authors

  • Penumetcha Sirisha B.Tech. Students, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India
  • Swetha M B.Tech. Students, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India
  • Sukesh Kalva Ph.D. Student, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India
  • Puneeth Bhargava B.Tech. Students, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India
  • N. Rathankar Assistant Professor, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India

Keywords:

PE/PPE proteins, antigenic variability, leprosy

Abstract

Antigenic variation in an infectious organism such as a protozoan, bacterium or virus alters its surface proteins in order to evade a host immune response. The consequences of this variation results in a heterogenic pathogenic population, in which individual cells either express the phase-variable protein(s) or express one of multiple antigenic forms of the protein, respectively [1]. This form of regulation has been identified for a wide variety of surface structures in animal pathogens and is implicated as a virulence strategy in diseases caused by mycobacterial genus. Antigenic variation in mycobacterial proteins have been identified due to the expression of PE/PPE proteins [2], which are unique to bacterial species and are absent in higher eukaryotes such as mouse and human genomes. Hence, inhibiting these proteins using suitable inhibitors may prevent this antigenic variation, which facilitates the bacterial recognition by the host immune system. An in-depth sequence analysis of PE/PPE proteins in Mycobacterium Leprae is presented in this paper for understanding its function and the paper concludes with design of inhibitors used to target these proteins using computational drug design approach

 

Author Biography

  • Penumetcha Sirisha, B.Tech. Students, Department of Bioinformatics, School of Bioengineering, Kattankulathur, SRM University, Kanchipuram District, Tamil Nadu 603203, India
    Dept. of Bioinformatics, Assistant professor

Downloads

Additional Files

Published

2013-09-30

Issue

Vol. 1 No. 1 (2012)

Section

Research/Review Articles

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is notpublished already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  • I/We also agree to the authorship of the article in the following order:

Author’s name

 

1. ________________

2. ________________

3. ________________

_______________

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.